Obtusifoliol

CAS No. 16910-32-0

Obtusifoliol( —— )

Catalog No. M21736 CAS No. 16910-32-0

Obtusifoliol is a metabolic intermediate of sterols made by certain fungis, can be converted to Delta8,14-Sterol by enzyme ERG11 (CYP51F1).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Obtusifoliol
  • Note
    Research use only, not for human use.
  • Brief Description
    Obtusifoliol is a metabolic intermediate of sterols made by certain fungis, can be converted to Delta8,14-Sterol by enzyme ERG11 (CYP51F1).
  • Description
    Obtusifoliol is a metabolic intermediate of sterols made by certain fungis, can be converted to Delta8,14-Sterol by enzyme ERG11 (CYP51F1).
  • In Vitro
    Obtusifoliol (0.1-100 μM; 48 hours) inhibit MCF-7 and MDA-MB231 breast cancer cells proliferation via arresting cell cycle progression and induction of apoptosis. Cell Viability Assay Cell Line:MCF-7; MDA-MB231 breast cancer cells Concentration:0.1, 1, 10, 40, 80, and 100 μM Incubation Time:48 hours Result:Inhibited MCF-7 and MDA-MB231 breast cancer cells proliferation.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    16910-32-0
  • Formula Weight
    426.729
  • Molecular Formula
    C30H50O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O[C@@H]1CC[C@@](C)2[C@@]([H])([C@H]1C)CCC1=C2CC[C@](C)2[C@]([H])([C@@H](C)CCC(=C)C(C)C)CC[C@@]21C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Cinpanemab

    Cinpanemab (BIIB054) is a novel human monoclonal antibody with affinity for alpha-synuclein residues 1-10. Cinpanemab can be used to study Parkinson's disease and related diseases.

  • Anidoxime HCl

    Anidoxime HCl (USVP-E142) is a novel orally available compound with anti-analgesic activity.

  • RXFP3/4 agonist 2

    RXFP3/4 agonist 2 is a potent, non-peptidic bis-RXFP3/4 agonist that facilitates the interaction between RXFP3 and β-arrestin-2 and is useful for studying diseases caused by metabolic abnormalities.